Life ScienceCompany
Merck KGaA - 5-HT2 Novel Compound Ownership
Who owns Merck KGaA - 5-HT2 Novel Compound?
Merck KGaA - 5-HT2 Novel Compound is owned by Eli Lilly. It was acquired on October 27, 2004.
Merck KGaA - 5-HT2 Novel Compound Business Overview
Where is Merck KGaA - 5-HT2 Novel Compound headquartered?
Merck KGaA - 5-HT2 Novel Compound is headquartered in Germany.
What sector is Merck KGaA - 5-HT2 Novel Compound in?
Merck KGaA - 5-HT2 Novel Compound is a life science company.
Life Science M&A Summary in 2004
Out of 60 sectors in the Mergr database, life science ranked 17 in number of deals in 2004. The largest life science acquisition in 2004 was Sicor - which was acquired by Teva Pharmaceutical Industries for $3.4B.
Join Mergr to view all 52 acquisitions of life science companies in 2004, including 12 acquisitions by private equity firms, and 40 by strategics.